The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evolution of the genomic landscape of circulating tumor DNA (ctDNA) in advanced prostate cancer (aPC) over treatment and time.
 
David D. Stenehjem
No Relationships to Disclose
 
Andrew W Hahn
No Relationships to Disclose
 
Roberto Nussenzveig
No Relationships to Disclose
 
Emma Carroll
No Relationships to Disclose
 
David Michael Gill
No Relationships to Disclose
 
Erin B. Bailey
No Relationships to Disclose
 
Julia Anne Batten
No Relationships to Disclose
 
Benjamin Louis Maughan
Consulting or Advisory Role - Janssen Oncology
 
Neeraj Agarwal
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Cerulean Pharma; Clovis Oncology; Eisai; EMD Serono; Exelixis; Genentech/Roche; Medivation/Astellas; Merck; Nektar; Novartis; Pfizer
Research Funding - Amgen (Inst); Bayer (Inst); BN ImmunoTherapeutics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Rexahn Pharmaceuticals (Inst); Takeda (Inst); TRACON Pharma (Inst)